MYCN is implicated in many pediatric embryonal tumors such as neuroblastoma (NB), rhabdomyosarcoma, medulloblastoma and more recently in therapy-resistant adult cancers including subtypes of breast cancer and prostate cancers (2,5). The gene discussed is MYCN; the disease is rhabdomyosarcoma.